Effect of age on outcome with primary angioplasty versus thrombolysis

Journal of the American College of Cardiology

Volumn 33, Issue 2, 1999, Pages 412-419

  Holmes Jr , David R ^a   White, Harvey D ^b   Pieper, Karen S ^c   Ellis, Stephen G ^d   Califf, Robert M ^c   Topol, Eric J ^d  

^a MAYO CLINIC   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRUDIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RECURRENCE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0033081816     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00579-8     Document Type: Article

References (24)

1. Gurivitz J.H., Goldberg R.J., Chen Z., et al. Recent trends in hospital mortality of acute myocardial infarction - the Worcester Heart Attack Study have improvements been realized for all age groups? Arch Intern Med. 154:1994;2202-2208.
2. Daida H., Kottke T.E., Backes R.J., et al. Are coronary unit changes in therapy associated with improved survival of elderly patients with acute infarction? Mayo Clin Proc. 72:1997;1014-1021.
3. Calle P., Jordaens L., De Buyzere M., et al. Age related differences in presentation, treatment, and outcome of acute myocardial infarction. Cardiology. 85:1994;111-120.
4. Califf R.M., Lee K.L., Granger C.B., Ohman E.M. Predictors of outcome of reperfusion therapy. Eur Heart J. 18:1997;728-735.
5. Forman D.E., Rich N.W. Management of acute myocardial infarction in the elderly. Drugs Aging. 8:1996;358-377.
6. Paul S.D., O'Gara P.T., Mahjoub Z.A. Geriatric patients with acute myocardial infarction cardiac risk factor profiles, presentations, thrombolysis, coronary interventions and prognosis. Am Heart J. 131:1996;710-715.
7. Hillis L.D., Forman S., Braunwald E., et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 15:1990;313-315.
8. Weaver W.D., Litwin P.E., Martin J.S., et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 18:1991;657-662.
9. Aguirre F.V., McMahon R.P., Mueller H., et al. Impact of age on clinical outcome and post lytic management strategies in patients treated with intravenous thrombolytic therapy results from the TIMI II study. Circulation. 90:1994;78-86.
10. White H.D., Barbash G.I., Califf R.M., et al. Age and outcome with contemporary thrombolytic therapy results from the GUSTO-I trial. Circulation. 94:1996;1826-1833.
11. Lee T.C., Laramee L.A., Rutherford B.D., et al. Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. Am J Cardiol. 66:1990;663-667.
12. Brodie B.R., Weingraub R.A., Stuckey T.D., et al. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non candidates for thrombolytic therapy. Am J Cardiol. 67:1991;7-12.
13. Stone G.W., Grines C.L., Browne K.F., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol. 25:1995;370-377.
14. Stone G.W., Grines C.L., Browne K., et al. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) investigators. Cathet Cardiovasc Diagn. 39:1996;333-339.
15. The GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628.
16. The GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 335:1996;775-782.
17. Stone C.J., Koo C.Y. Additive splines in statistics. Proc Stat Comp Section, Am Stat Assoc. 1985;45-48.
18. Walker S.H., Duncan D.B. Estimation of the probability of an event as a function of several independent variables. Appl Stat. 37:1967;87-94.
19. Holland K.J., O'Neill W.W., Bates E.R., Pitt B., Topol E.J. Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. Am J Cardiol. 63:1989;399-403.
20. Mickelson J.K., Blum C.M., Geraci J.M. Acute myocardial infarction clinical characteristics management and outcome in a metropolitan Veterans Affairs Medical Central teaching hospital . J Am Coll Cardiol. 29:1997;915-925.
21. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction a quantitative review. JAMA. 278:1997;2093-2098.
22. Chandra H., Yarzebski J., Goldberg R.J., et al. Age related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. Arch Intern Med. 157:1997;741-746.
23. Fibrinolytic Therapy Trialists (FTT) Collaborative Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 343:1994;311-322.
24. Krumholz H.M., Pasternak R.C., Weinstein M.C. Cost-effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med. 327:1992;7-13.